Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Otitis externa treatment can lead to yeast overgrowth, study finds
“It was most gratifying to be able to confirm our previous observations by use of semi-quantitative cultures” – Ross Bond.
Antibiotic use led to increases in Malassezia pachydermatis.

Scientists are advising veterinary surgeons to monitor for yeast overgrowth in patients that are treated with antibiotics for otitis externa, following a new study.

Although the findings of the research were expected, the phenomenon had not previously been well described in veterinary literature.

Researchers at the Royal Veterinary College (RVC) studied 29 dogs treated with fluoroquinolone or piperacillin-tazobactam for bacterial otitis externa. The dogs were mostly referred with chronic otitis externa after unsuccessful treatment using licensed products.

Ear swabs were taken before and after treatment for cytological evaluation and semi-quantitative culture.

Although bacteria counts significantly decreased after treatment, otic yeast increased, especially Malassezia pachydermatis. This outcome was more common in cases treated with piperacillin-tazobactam.

The researchers believe that increases in yeast were seen because of the antibacterial treatment suppressing bacteria that normally compete with yeast growth and inhibit it.

Further research is needed to find out if antifungal drugs or antiseptic ear rinses can be used to prevent fungal growth when antibiotics are used to treat otitis externa.

Ross Bond, professor of veterinary dermatology at RVC and corresponding author of the study, said: “We are very grateful to BSAVA PetSavers for kindly funding this study and to the owners of the dogs for agreeing to participate.

“It was most gratifying to be able to confirm our previous observations by use of semi-quantitative cultures.

“Our next goal is to find treatment protocols that prevent the fungal dysbiosis without compromising the efficacy of the antibacterial therapy in these very difficult ear cases.”

The study has been published in the Journal of Small Animal Practice.

Image © Shutterstock

Become a member or log in to add this story to your CPD history

Webinar to explore AMR in vet dentistry

News Story 1
 The WSAVA has invited veterinary professionals to a webinar on responsible antibiotic usage in dentistry.

On 19 November 2025, at 1am, Dr J Scott Weese and Dr Brooke Niemiec will share the latest advice for antimicrobial use. They will present research on oral bacterology, and explain how attendees can choose appropriate antibiotics.

The session will cover pre-, intra- and post-operative guidelines, with recommendations for various pathologies.

The webinar is designed to support veterinary professionals to make informed decisions and tackle antimicrobial resistance.

Attendees can register here

Click here for more...
News Shorts
Dechra launches checklist for veterinary sustainability

Global animal health specialist Dechra has announced the world's first Veterinary Green Theatre Checklist (VGTC) to help make surgery more sustainable.

Endorsed by leading veterinary organisations, including the BEVA, BVNA and RCVS Knowledge, the checklist is designed to reduce the environmental footprint of veterinary care, while supporting better animal health outcomes.

The checklist was launched at the World Congress of Veterinary Anaesthesia and Analgesia in Paris and will be followed by an internal training and awareness campaign. For more information, visit dechra.com